A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology.

PLoS Negl Trop Dis · 2012 · PMC3313938 · PMID 22479658

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

extremely significantp <0.001actually significant

Differences were considered statistically significant at p <0.05, very significant at p <0.01 and extremely significant at p <0.001.

also in 5,999 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.